# OnCo record paper-nguyen-trastuzumab-adjuvant-cea-vietnam-plos-one-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nguyen-trastuzumab-adjuvant-cea-vietnam-plos-one-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nguyen-trastuzumab-adjuvant-cea-vietnam-plos-one-2024" ;
  schema:name "Cost-effectiveness of one-year adjuvant trastuzumab therapy in treatment for early-stage breast cancer patients with HER2+ in Vietnam"@en ;
  schema:description "Trastuzumab is reimbursed at 60% by Viet Nam's social health insurance; this model found a year of adjuvant trastuzumab cost 519.6 million dong (22,845 US dollars) per quality-adjusted life year gained, above thresholds of one and three times GDP per head."@en ;
  schema:url <https://onco.cc/key-papers/paper-nguyen-trastuzumab-adjuvant-cea-vietnam-plos-one-2024/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1371/journal.pone.0300474>, <https://pubmed.ncbi.nlm.nih.gov/38489305/> ;
  schema:sameAs <https://doi.org/10.1371/journal.pone.0300474> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Nguyen AQ, Tran OTM, Nguyen PK, Nguyen HT" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/trastuzumab-biosimilars/> ;
  onco:institutions <https://onco.cc/institutions/vss-vietnam/> ;
  onco:terms <https://onco.cc/terms/hta/> .